FP
LFCR icon

Foundry Partners’s Lifecore Biomedical LFCR Stock Holding History

Foundry Partners’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-199,620
Closed -$2.26M – 400
2019
Q4 		$2.26M Sell
199,620
-18,275
-8% -$194K 0.09% 252
2019
Q3 		$2.37M Sell
217,895
-13,050
-6% -$142K 0.1% 242
2019
Q2 		$2.16M Sell
230,945
-1,975
-0.8% -$19.9K 0.09% 253
2019
Q1 		$2.86M Sell
232,920
-55,030
-19% -$672K 0.11% 237
2018
Q4 		$3.41M Sell
287,950
-113,725
-28% -$1.56M 0.15% 205
2018
Q3 		$5.78M Sell
401,675
-23,515
-6% -$325K 0.22% 173
2018
Q2 		$6.33M Sell
425,190
-50
-0% -$695 0.26% 161
2018
Q1 		$5.55M Buy
425,240
+3,875
+0.9% +$50.9K 0.24% 167
2017
Q4 		$5.31M Sell
421,365
-16,025
-4% -$203K 0.22% 174
2017
Q3 		$5.66M Buy
437,390
+24,400
+6% +$322K 0.23% 173
2017
Q2 		$6.13M Buy
412,990
+3,275
+0.8% +$45.6K 0.25% 135
2017
Q1 		$4.92M Buy
409,715
+55,900
+16% +$708K 0.21% 183
2016
Q4 		$4.88M Buy
353,815
+86,615
+32% +$1.2M 0.21% 181
2016
Q3 		$3.58M Buy
267,200
+3,275
+1% +$39.7K 0.19% 172
2016
Q2 		$2.84M Buy
263,925
+850
+0.3% +$9.38K 0.16% 215
2016
Q1 		$2.76M Buy
263,075
+80,110
+44% +$880K 0.27% 120
2015
Q4 		$2.16M Buy
+182,965
New +$2.25M 0.18% 159

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return

Foundry Partners's LFCR Position: Q1 2020 in Review

Foundry Partners sold out of Lifecore Biomedical (LFCR) in Q1 2020, closing a stake of 199,620 shares — an estimated $2.26M sold.

Foundry Partners first reported a position in LFCR in Q4 2015 and held it in 17 quarters. The position peaked at $6.33M in Q2 2018. 88 funds tracked by Wall St. Rank hold LFCR as of Q1 2020.

  • Foundry Partners reported no remaining Lifecore Biomedical position as of Q1 2020 after selling out during the quarter.
  • Foundry Partners sold 199,620 Lifecore Biomedical shares in Q1 2020, an estimated $2.26M.
  • Foundry Partners first reported a position in Lifecore Biomedical in Q4 2015 and held it in 17 quarters.
  • Foundry Partners's Lifecore Biomedical position peaked at $6.33M in Q2 2018.
  • 88 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2020.

Based on Foundry Partners's 13F filing for Q1 2020, filed 8 May 2020.